Prenatal hormonal therapy improves pulmonary morphology in rats with congenital diaphragmatic hernia

Journal of Surgical Research

Volumn 65, Issue 1, 1996, Pages 42-52

  Losty, Paul D ^a   Pacheco, Bella A ^a   Manganaro, Thomas F ^a   Donahoe, Patricia K ^a   Jones, Rosemary C ^a   Schnitzer, Jay J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; NITROFEN; PROTIRELIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; HORMONAL THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG DEVELOPMENT; LUNG HYPOPLASIA; NONHUMAN; PRENATAL PERIOD; PRIORITY JOURNAL; RAT; RESPIRATORY DISTRESS SYNDROME;

EID: 0030249203     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0341     Document Type: Article

References (48)

1. 1. Mallik, K., Rodgers, B. M., and McGahren, E. D. Congenital diaphragmatic hernia: experience in a single institution from 1978 through 1994. Ann. Thorac. Surg. 60: 1331, 1995.
2. 2. Heiss, K. F., and Clark, R. H. Prediction of mortality in neonates with congenital diaphragmatic hernia with extracorporeal membrane oxygenation. Crit. Care Med. 23: 1915, 1995.
3. 3. Steinhorn, R. H., Kriesmer, P. J., Green, T. P., et al. Congenital diaphragmatic hernia in Minnesota: Impact of antenatal diagnosis on survival. Arch. Pediatr. Adolesc. Med. 148: 626, 1994.
4. 4. Lessin, M. S., Thompson, I. M., Deprez, M. F., et al. Congenital diaphragmatic hernia with or without extracorporeal membrane oxygenation: Are we making progress? J. Am. Coll. Surg. 181: 65, 1995.
5. 5. Wilson, J. M., Lund, D. P., Lillehei, C. W., et al. Congenital diaphragmatic hernia: Predictors of severity in the ECMO era. J. Pediatr. Surg. 26: 1028, 1991.
6. 6. Harrison, M. R., Adzick, N. S., Estes, J. M., et al. A prospective study of the outcome for fetuses with diaphragmatic hernia. JAMA 271: 382, 1994.
7. 7. Harrison, M. R., Adzick, N. S., and Flake, A. W. Congenital diaphragmatic hernia: An unsolved problem. Semin. Pediatr. Surg. 2: 109, 1993.
8. 8. Blackburn, W. R., Logsdon, P., and Alexander, J. A. Congenital diaphragmatic hernia: Studies of lung composition and structure. Am. Rev. Respir. Dis. 115(suppl.): 275, 1977.
9. 9. Wigglesworth, J. S., Desai, R., and Guerrini, P. Fetal lung hypoplasia: Biochemical and structural variations and their possible significance. Arch. Dis. Child. 56: 606, 1981.
10. 10. Berk, C., and Grundy, M. 'High risk' lecithin/sphingomyelin ratios associated with neonatal diaphragmatic hernia: Case reports. Br. J. Obstet. Gynecol. 89: 250, 1982.
11. 11. George, D. K., Cooney, T. P., Chiu, B. K., et al. Hypoplasia and immaturity of the terminal lung unit (acinus) in congenital diaphragmatic hernia. Am. Rev. Respir. Dis. 136: 947, 1987.
12. 12. Hisanaga, S., Shimokawa, H., Kashiwabara, Y., et al. Unexpectedly low lecithin/sphingomyelin ratio associated with fetal diaphragmatic hernia. Am. J. Obstet. Gynecol. 149: 905, 1984.
13. 13. Nakayama, D. K., Motoyama, E. K., and Tagge, E. M. Effect of preoperative stabilization on respiratory system compliance and outcome in newborn infants with congenital diaphragmatic hernia. J. Pediatr. 118: 793, 1991.
14. 14. Harrison, M. R., Adzick, N. S., Flake, A. W., et al. Correction of congenital diaphragmatic hernia in utero: VI. Hard-earned lessons. J. Pediatr. Surg. 28: 1411, 1993.
15. 15. DiFiore, J. W., Fauza, D. O., Slavin, R., et al. Experimental fetal tracheal ligation reverses the structural and physiological effects of pulmonary hypoplasia in congenital diaphragmatic hernia. J. Pediatr. Surg. 29: 248, 1994.
16. 16. Suen, H. C., Bloch, K. D., and Donahoe, P. K. Antenatal glucocorticoid corrects pulmonary immaturity in experimental congenital diaphragmatic hernia rats. Pediatr. Res. 35: 523, 1994.
17. 17. Suen, H. C., Losty, P., Donahoe, P. K., and Schnitzer, J. J. Combined antenatal thyrotropin-releasing hormone and low-dose glucocorticoid therapy improves the pulmonary biochemical immaturity in congenital diaphragmatic hernia. J. Pediatr. Surg. 29: 359, 1994.
18. 18. Losty, P. D., Suen, H. C., Manganaro, T. F., Donahoe, P. K., and Schnitzer, J. J. Prenatal hormonal therapy improves pulmonary compliance in the nitrofen induced CDH rat model. J. Pediatr. Surg. 30: 420, 1995.
19. 19. Liggins, G. C., and Howie, R. N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50: 515, 1972.
20. 20. Ballard, R. A., Ballard, P. L., Creasy, R. K., et al. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. Lancet 339: 510, 1992.
21. 21. NIH Consensus Development Conference. Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Bethesda, MD: National Institutes of Health, 1994.
22. 22. Kluth, D., Kangah, P., Reich, P., et al. Nitrofen-induced diaphragmatic hernias in rats: An animal model. J. Pediatr. Surg. 25: 850, 1990.
23. 23. Suen, H. C., Catlin, E. A., Ryan, D. P., et al. Biochemical immaturity of lungs in congenital diaphragmatic hernia. J. Pediatr. Surg. 28: 471, 1993.
24. 24. Emery, J. L., and Mithal, A. The number of alveoli in the terminal respiratory unit of man during late intrauterine life and childhood. Arch. Dis. Child. 35: 544, 1960.
25. 25. Weibel, E. R. (Ed.). Stereologic Methods: Vol. 1. Practical Methods for Biological Morphometry. London: Academic Press, 1979.
26. 26. Burri, P. The postnatal growth of the rat lung. I. Morphometry. Anat. Rec. 178: 711, 1974.
27. 27. Scherle, W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26: 57, 1970.
28. 28. Askenazi, S. S., and Perlman, M. Pulmonary hypoplasia: Lung weight and radial alveolar count as criteria of diagnosis. Arch. Dis. Child. 54: 614, 1979.
29. 29. Zar, J. H. Biostatistical Analysis. 2nd ed. Englewood Cliffs, NJ: Prentice Hall, 1984.
30. 30. Lotze, A., Knight, G. R., Anderson, K. D., et al. Surfactant (Beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: Evidence of persistent surfactant deficiency. J. Pediatr. Surg. 29: 407, 1994.
31. 31. Roberts, J. D., Polaner, D. M., Lang, P., et al. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818, 1992.
32. 32. Adzick, N. S. Neonatal lung transplantation. Arch. Dis. Child. 67: 455, 1992.
33. 33. Liggins, G. C. Premature delivery of fetal lambs infused with glucocorticoids. J. Endocrinol. 45: 515, 1969.
34. 34. Kotas, R. V., and Avery, M. E. Accelerated appearance of pulmonary surfactant in the fetal rabbit. J. Appl. Physiol. 30: 358, 1971.
35. 35. Mitzner, W., Johnson, J. W. C., Scott, R., et al. Effect of betamethasone on pressure-volume relationships of fetal rhesus monkey lung. J. Appl. Physiol. 47: 377, 1979.
36. 2 exposure. Pediatr. Res. 32: 407, 1992.
37. 37. Kikkawa, Y., Kaibara, M., Motoyama, E. K., et al. Morphologic development of fetal rabbit lung and its acceleration with cortisol. Am. J. Pathol. 64: 423, 1971.
38. 38. Kitterman, J. A., Liggins, G. C., Campos, G. A., et al. Prepartum maturation of the lung in fetal sheep: Relation to cortisol. J. Appl. Physiol. 51: 384, 1981.
39. 39. Massaro, D., and Massaro, G. D. Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition. Am. J. Physiol. 251: R218, 1986.
40. 40. Snyder, J. M., Rodgers, H. F., O'Brien, J. A., et al. Glucocorticoid effects on rabbit fetal lung maturation in vivo: An ultrastructural morphometric study. Anat. Rec. 232: 133, 1992.
41. 41. Rooney, S. A., Marino, P. A., Gobran, L. I., et al. Thyrotropin-releasing hormone increases the amount of surfactant in lung lavage from fetal rabbits. Pediatr. Res. 13: 623, 1979.
42. 42. Devaskar, U., Nitta, K., Szewczyk, K., et al. Transplacental stimulation of functional and morphologic fetal rabbit lung maturation: Effect of thyrotropin-releasing hormone. Am. J. Obstet. Gynecol. 157: 460, 1987.
43. 43. Ikegami, M., Polk, D., Tabor, B., et al. Corticosteroid and thyrotropin-releasing hormone effects on preterm sheep lung function. J. Appl. Physiol. 70: 2268, 1991.
44. 44. Hedrick, H. L., Pacheco, B. A., Losty, P. D., et al. Dexamethasone increases expression of surfactant associated protein mRNA in rats with nitrofen-induced congenital diaphragmatic hernia. Surg. Forum 46: 654, 1995.
45. 45. Phelps, D. S., and Floros, J. Dexamethasone in vivo raises surfactant protein B mRNA in alveolar and bronchiolar epithelium. Am. J. Physiol. 260: L161, 1991.
46. 46. Weaver, T. E., and Whitsett, J. A. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem. J. 273: 249, 1991.
47. 47. Boshier, D. P., Holloway, H., Liggins, G. C., et al. Morphometric analyses of the effects of thyrotropin releasing hormone and cortisol on the lungs of fetal sheep. J. Dev. Physiol. 12: 49, 1989.
48. 48. Lau, C., Cameron, A. M., Irsula, O., et al. Teratogenic effects of nitrofen on cellular and functional maturation of the rat lung. Toxicol. Appl. Pharmacol. 95: 412, 1988.